Business StandardCenter·
Ichnos Glenmark files US FDA application for solid tumour drug ISB 2301
The Glenmark-Ichnos joint venture has sought US FDA clearance for its experimental cancer drug ISB 2301, with Phase I clinical trials in patients with solid tumours planned for 2027
Read at Business Standard →



